Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma

Affiliations

• ¹ Department of Hematology, Myeloma & Lymphoma Center, Second Affiliated Hospital of Naval Medical University, 200003, Shanghai, China.
• ² Hongyuan Biotech, Biobay, Suzhou, China.
• ³ Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, VIC, Australia.
• ⁴ Malignant Hematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, VIC, Australia.
• ⁵ Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
• ⁶ Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London, UK.
• ⁷ Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, 200003, Shanghai, China. taoxia2003@163.com.
• ⁸ National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China. drwudepei@163.com.
• ⁹ Department of Hematology, Myeloma & Lymphoma Center, Second Affiliated Hospital of Naval Medical University, 200003, Shanghai, China. juan_du@live.com.